Zura Bio
Marlyn Mathew is currently the Vice President of Finance and Accounting at Zura Bio Limited. Prior to this, Marlyn held roles such as Controller and Assistant Controller at Immunovant, Manager of Financial Planning Analysis and Senior Accountant at Roivant Sciences, and Senior Accountant at Par Pharmaceutical and Russian Standard Vodka. Marlyn started their accounting career as an Accountant at Medco Health Solutions after graduating from Rutgers University with a BS in Accounting.
Zura Bio
1 followers
Zura Bio is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. Currently, Zura Bio is developing three assets which have completed phase 1/1b studies and are Phase 2 ready. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), torudokimab (ZB-880), and ZB-168 with a goal of demonstrating their efficacy, safety, and dosing convenience in immune and inflammatory disorders. Zura Bio is headquartered in Henderson, NV with team members in the UK and USA.